France Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
Summary
Pharmaceuticals in France industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The French pharmaceuticals market had total revenues of $74.9 billion in 2022, representing a compound annual growth rate (CAGR) of 3.7% between 2017 and 2022.
- 0
- The French market acquired a 21.2% share of the European pharmaceuticals market in 2022. The growth in the pharmaceuticals market is mainly due to an increase in pharmaceutical spending by the government. According to the most recent data available from the OECD, pharmaceutical spending in France stood at 12.5% of total health spending in 2021.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in France
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in France
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the France pharmaceuticals market with five year forecasts by both value and volume
- What was the size of the France pharmaceuticals market by value in 2022?
- What will be the size of the France pharmaceuticals market in 2027?
- What factors are affecting the strength of competition in the France pharmaceuticals market?
- How has the market performed over the last five years?
- How large is France’s pharmaceuticals market in relation to its regional counterparts?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Geography segmentation
- 1.4. Market rivalry
- 1.5. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What strategies do leading players follow?
- 7.3. What are the most recent market developments?
- 8 Company Profiles
- 8.1. Sanofi SA
- 8.2. Laboratoires Pierre Fabre SA
- 8.3. Les Laboratoires Servier
- 8.4. AstraZeneca PLC
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: France pharmaceuticals market value: $ billion, 2017-22
- Table 2: France pharmaceuticals market geography segmentation: $ billion, 2022
- Table 3: France pharmaceuticals market value forecast: $ billion, 2022-27
- Table 4: Sanofi SA: key facts
- Table 5: Sanofi SA: Annual Financial Ratios
- Table 6: Sanofi SA: Key Employees
- Table 7: Sanofi SA: Key Employees Continued
- Table 8: Laboratoires Pierre Fabre SA: key facts
- Table 9: Laboratoires Pierre Fabre SA: Key Employees
- Table 10: Les Laboratoires Servier: key facts
- Table 11: Les Laboratoires Servier: Key Employees
- Table 12: AstraZeneca PLC: key facts
- Table 13: AstraZeneca PLC: Annual Financial Ratios
- Table 14: AstraZeneca PLC: Key Employees
- Table 15: AstraZeneca PLC: Key Employees Continued
- Table 16: France size of population (million), 2018-22
- Table 17: France gdp (constant 2005 prices, $ billion), 2018-22
- Table 18: France gdp (current prices, $ billion), 2018-22
- Table 19: France inflation, 2018-22
- Table 20: France consumer price index (absolute), 2018-22
- Table 21: France exchange rate, 2018-22
- List of Figures
- Figure 1: France pharmaceuticals market value: $ billion, 2017-22
- Figure 2: France pharmaceuticals market geography segmentation: % share, by value, 2022
- Figure 3: France pharmaceuticals market value forecast: $ billion, 2022-27
- Figure 4: Forces driving competition in the pharmaceuticals market in France, 2022
- Figure 5: Drivers of buyer power in the pharmaceuticals market in France, 2022
- Figure 6: Drivers of supplier power in the pharmaceuticals market in France, 2022
- Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2022
- Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2022
- Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in France, 2022
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook